HRT Financial’s ImmunityBio IBRX Stock Holding History

HRT Financial’s Portfolio IBRX Stock Details IBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$30.1M	Buy	+3,925,446	New	+$26.9M	0.12%	227
2025 Q2	–	Sell	-237,761	Closed	-$715K	–	3088
2025 Q1	$715K	Buy	+237,761	New	+$721K	0.01%	1289
2024 Q3	–	Sell	-67,782	Closed	-$428K	–	2772
2024 Q2	$428K	Buy	+67,782	New	+$447K	﹤0.01%	1359
2023 Q2	–	Sell	-69,888	Closed	-$127K	–	2837
2023 Q1	$127K	Buy	+69,888	New	+$217K	﹤0.01%	2018
2022 Q3	–	Sell	-54,717	Closed	-$203K	–	3140
2022 Q2	$203K	Buy	54,717 +16,875	+45%	+$67.8K	﹤0.01%	2237
2022 Q1	$212K	Buy	+37,842	New	+$232K	﹤0.01%	2458
2021 Q2	–	Sell	-93,764	Closed	-$2.23M	–	3165
2021 Q1	$2.23M	Buy	+93,764	New	+$2.43M	0.03%	565
2019 Q1	–	Sell	-17,042	Closed	-$19K	–	650
2018 Q4	$19K	Buy	+17,042	New	+$39K	﹤0.01%	553

Other funds holding IBRX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return